Basics Rockwell Medical, Inc. (DE) Common Stock Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis. IPO Date: February 1, 1998 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $38.89M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.84% Avg Daily Range (30 D): $0.03 | 2.63% Avg Daily Range (90 D): $0.05 | 3.73% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .28M Avg Daily Volume (90 D): 1M Trade Size Avg Trade Size (Sh.): 301 Avg Trade Size (Sh.) (30 D): 297 Avg Trade Size (Sh.) (90 D): 310 Institutional Trades Total Inst.Trades: 185 Avg Inst. Trade: $1.17M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.46M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 30.67K     News Aug 14, 2025 @ 10:21 AM Rockwell Medical Tops Q2 EPS View Source: Jesterai Oct 9, 2024 @ 8:12 PM DaVita Stock Gains 47.3% Year to Date: What's Behi... Source: Zacks, Benzinga Contributor May 14, 2024 @ 11:15 AM Rockwell Medical (RMTI) Reports Q1 Loss, Tops Reve... Source: Zacks Equity Research Mar 26, 2024 @ 10:15 PM Rockwell Medical (RMTI) Increases Despite Market S... Source: Zacks Equity Research Mar 21, 2024 @ 11:10 AM Rockwell Medical (RMTI) Q4 Earnings and Revenues B... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.18 $-.05 $-.05 Diluted EPS $-.18 $-.05 $-.05 Revenue $ 75.58M $ 15.93M $ 16.07M Gross Profit $ 11.45M $ 2.27M $ 2.5M Net Income / Loss $ -5.52M $ -1.75M $ -1.49M Operating Income / Loss $ -4.81M $ -1.58M $ -1.35M Cost of Revenue $ 64.13M $ 13.66M $ 13.57M Net Cash Flow $ 1.27M $ 1.13M $ 1.09M PE Ratio     Splits May 13, 2022:   1:11